These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 11992965)

  • 61. Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain.
    Carignan A; Allard C; Pépin J; Cossette B; Nault V; Valiquette L
    Clin Infect Dis; 2008 Jun; 46(12):1838-43. PubMed ID: 18462108
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clostridium difficile ribotypes 027 and 106: clinical outcomes and risk factors.
    Sundram F; Guyot A; Carboo I; Green S; Lilaonitkul M; Scourfield A
    J Hosp Infect; 2009 Jun; 72(2):111-8. PubMed ID: 19386381
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clostridium difficile: improving the prevention paradigm in healthcare settings.
    Vassallo A; Tran MC; Goldstein EJ
    Expert Rev Anti Infect Ther; 2014 Sep; 12(9):1087-102. PubMed ID: 25109301
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clostridium difficile infection in Manchester.
    Commun Dis Rep CDR Wkly; 1992 Jan; 2(3):9. PubMed ID: 1285174
    [No Abstract]   [Full Text] [Related]  

  • 65. Recognizing and managing Clostridium difficile-associated diarrhea.
    Miller JM; Walton JC; Tordecilla LL
    Medsurg Nurs; 1998 Dec; 7(6):348-9, 352-6. PubMed ID: 10036439
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clostridium difficile-associated diarrhoea rates and global antibiotic consumption in five Quebec institutions from 2001 to 2004.
    Weiss K; Bergeron L; Bernatchez H; Goyette M; Savoie M; Thirion D
    Int J Antimicrob Agents; 2007 Oct; 30(4):309-14. PubMed ID: 17644347
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Infection control practices related to Clostridium difficile infection in acute care hospitals in Canada.
    Gravel D; Gardam M; Taylor G; Miller M; Simor A; McGeer A; Hutchinson J; Moore D; Kelly S; Mulvey M;
    Am J Infect Control; 2009 Feb; 37(1):9-14. PubMed ID: 19171246
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-René-Muret hospitals from 2001 to 2007].
    Poilane I; Fantinato C; Cruaud P; Collignon A
    Pathol Biol (Paris); 2008; 56(7-8):412-6. PubMed ID: 18842360
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Single-dose cefuroxime with gentamicin reduces Clostridium difficile-associated disease in hip-fracture patients.
    Starks I; Ayub G; Walley G; Orendi J; Roberts P; Maffulli N
    J Hosp Infect; 2008 Sep; 70(1):21-6. PubMed ID: 18621442
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clostridium difficile in London and Staffordshire.
    Commun Dis Rep CDR Wkly; 1992 Feb; 2(6):25. PubMed ID: 1285182
    [No Abstract]   [Full Text] [Related]  

  • 71. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain.
    Valiquette L; Cossette B; Garant MP; Diab H; Pépin J
    Clin Infect Dis; 2007 Sep; 45 Suppl 2():S112-21. PubMed ID: 17683015
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Molecular and clinical characteristics of Clostridium difficile infection in a University Hospital in Shanghai, China.
    Huang H; Wu S; Wang M; Zhang Y; Fang H; Palmgren AC; Weintraub A; Nord CE
    Clin Infect Dis; 2008 Dec; 47(12):1606-8. PubMed ID: 19025371
    [No Abstract]   [Full Text] [Related]  

  • 73. New views on Clostridium difficile infections: Introduction.
    Rodloff A; Gould I
    Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S1. PubMed ID: 19303561
    [No Abstract]   [Full Text] [Related]  

  • 74. Clostridium difficile infection: a new threat on our doorstep.
    Stuart RL; Marshall C
    Med J Aust; 2011 Apr; 194(7):331-2. PubMed ID: 21470079
    [No Abstract]   [Full Text] [Related]  

  • 75. Clostridium difficile--setting the scene.
    Wilcox MH
    J Antimicrob Chemother; 1998 May; 41 Suppl C():1-3. PubMed ID: 9630368
    [No Abstract]   [Full Text] [Related]  

  • 76. International Infection Control Council. Global consensus conference on infection prevention and control practice for Clostridium difficile associated disease (CDAD).
    Can J Infect Control; 2008; 23(2):110-1. PubMed ID: 18811105
    [No Abstract]   [Full Text] [Related]  

  • 77. Immunization strategies for Clostridium difficile infections.
    Rebeaud F; Bachmann MF
    Expert Rev Vaccines; 2012 Apr; 11(4):469-79. PubMed ID: 22551032
    [TBL] [Abstract][Full Text] [Related]  

  • 78. First cluster of C. difficile toxinotype III, PCR-ribotype 027 associated disease in France: preliminary report.
    Tachon M; Cattoen C; Blanckaert K; Poujol I; Carbonne A; Barbut F; Petit JC; Coignard B
    Euro Surveill; 2006 May; 11(5):E060504.1. PubMed ID: 16816455
    [No Abstract]   [Full Text] [Related]  

  • 79. Outbreak from a high-toxin intruder: Clostridium difficile.
    Norén T
    Lancet; 2005 Sep 24-30; 366(9491):1053-4. PubMed ID: 16182878
    [No Abstract]   [Full Text] [Related]  

  • 80. Epidemiology and predictors of recurrence of Clostridium difficile infection in a North Italian tertiary care hospital.
    Bassetti M; Astilean A; Arzese A; Cimarosti R; Barbone F; Pecori D
    J Gastrointestin Liver Dis; 2014 Dec; 23(4):459-60. PubMed ID: 25532010
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.